# Evaluation of the Safety and Efficacy of N-desmethylclobazam in Patients With Peripheral Neuropathic Pain

> **NCT04480164** · PHASE2 · SUSPENDED · sponsor: **Besson Marie** · enrollment: 76 (estimated)

## Conditions studied

- Neuropathic Pain

## Interventions

- **DRUG:** NDMC

## Key facts

- **NCT ID:** NCT04480164
- **Lead sponsor:** Besson Marie
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2020-06-24
- **Primary completion:** 2022-09-01
- **Final completion:** 2023-05-31
- **Target enrollment:** 76 (ESTIMATED)
- **Why stopped:** low recruitment rate and end of study finding
- **Last updated:** 2023-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04480164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04480164, "Evaluation of the Safety and Efficacy of N-desmethylclobazam in Patients With Peripheral Neuropathic Pain". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04480164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*